Mithra receives guidance from the FDA for the DONESTA® NDA marketing authorization filing in the United States Mithra receives guidance from the FDA for the DONESTA® NDA marketing authorization filing in the United States DONESTA® for the treatment of vasomotor symptoms of menopause, is expected to target...